# QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001

> **NCT05092438** · — · COMPLETED · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 595 (actual)

## Conditions studied

- Meningitis/Encephalitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05092438
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-08
- **Primary completion:** 2021-12-02
- **Final completion:** 2021-12-02
- **Target enrollment:** 595 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05092438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05092438, "QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05092438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*